Elanco Animal Health: Q2 Earnings Insights

07:03am, Monday, 09'th Aug 2021
Shares of Elanco Animal Health (NYSE:ELAN) rose 0.1% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 211.11% over the past year to $0.28, whic
Elanco Animal Health Inc. ELAN, -1.23% reported Monday second-quarter profit that topped expectations and revenue that more than doubled, amid strength in the U.S. vaccine business and international m
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today reported financial results for the second quarter of 2021, provided guidance for the third quarter of 2021, and
NORWALK, Conn., Aug. 2, 2021 /PRNewswire/ -- TriRx Pharmaceutical Services, LLC, a leading international CDMO, announced today that it has finalized and closed on an agreement with Elanco Animal Hea
Elanco Animal Health Incorporated (ELAN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly re
The pet health company buys yet another business in an effort to fast-track growth and expand its offerings.
We believe that the stock price of Elanco, a pharmaceuticals company focused on medicines for pets and livestock, has more room for growth from its current levels of $35. ELAN stock is up 2x from the
These penny stocks under $1 have the potential to trend higher. They are the stocks of businesses with decent fundamentals.
Elanco Animal Health Inc (NYSE: ELAN) said on Wednesday it will acquire Kindred Biosciences Inc (NASDAQ: KIN) for roughly $440 million (£312 million) to expand its footprint in the pet health industr
Elanco Animal Health said it struck a $440 million deal to acquire Kindred Biosciences, a move that will bolster its drug pipeline, particularly the fast-growing pet dermatology segment.
Elanco Animal Health Inc. said Wednesday it has entered an agreement to acquire Kindred Biosciences Inc. for about $440 million, adding three potential dermatology blockbusters to its pipeline. Under

Hold Elanco Despite Litigation Risks

05:00am, Wednesday, 16'th Jun 2021
Hold Elanco Despite Litigation Risks
NORWALK, Conn., June 15, 2021 /PRNewswire/ -- TriRx Pharmaceutical Services Inc., a leading international CDMO, today announced an agreement to acquire two facilities from Elanco Animal Health Incor
The physiological and psychological benefits that pets give us are meaningful. COVID has amplified our appreciation of this. Anticipating 6% annual growth until 2030 may be conservative, even across d
Here are some MedTech stocks with favorable PEG ratio, which are expected to provide gains in 2021.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE